Umary Acid Hyaluronic recall: CGMP Deviations
UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
Why was Umary Acid Hyaluronic recalled?
cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot#: 24183, Exp 07/01/28
- Product
- UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
- Recalling firm
- MXBBB
- Quantity
- 321 bottles
- Distribution
- Product was sold via Amazon Marketplace.
- Recall date
- January 1, 2025
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)